Orion Pharma
Manufacturing · Finland · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Orionintie 1a, Espoo, Uusimaa, 02101, Fi...Website
www.orionpharma.comRevenue
$1.2 BillionIndustry
About Orion Pharma
Orion Pharma Org Chart
Is Orion Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Orion Pharma recently announced quarterly report
Product Launch: Get notified when Orion Pharma launches new products
Click to see if Orion Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Orion Pharma is spiking on competitors!
Funding: Get notified immidiatlly once Orion Pharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Orion Pharma
Check if Orion Pharma has recently received funding, and reach out quickly before it becomes old news!
Orion Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Orion Pharma
Find 2 more new buyers
Company Profile Activity
Activity Insights
Orion Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orion Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orion Pharma.
Orion Pharma Tech Stack
A closer look at the technologies used by Orion Pharma
Most Recent Scoops
Orion Pharma News & Media
102,000 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 4 SEPTEMBER 2026 at 9.00 EESTOrion Corporation to commence acquisition of own shares for its share-based incentive plans
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 AUGUST 2026 at 13.00 EESTOrion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 10 AUGUST 2026 at 14.05 EESTOrion Corporation’s financial reporting and Annual General Meeting in 2027
ORION CORPORATION STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR 17 JULY 2026 at 10.30 EEST
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orion Pharma
Orion Corp is a company that operates in the Pharmaceuticals industry. It employs 1000to4999 people and has 1Gto5G of revenue. The company is headquartered in Espoo, Uusimaa, Finland.... Read More